Abstract Background Anti-angiogenic therapy has great potential for cancer therapy with several FDA approved formulations but there are considerable side effects upon the normal blood vessels that decrease the potential application of such therapeutics. Chicken chorioallantoic membrane (CAM) has been used as a model to study angiogenesis in vivo. Using a CAM model, it had been previously shown that spherical gold nanoparticles functionalised with an anti-angiogenic peptide can humper neo-angiogenesis. Results Our results show that gold nanoparticles conjugated with an anti-angiogenic peptide can be combined with visible laser irradiation to enhance angiogenesis arrest in vivo. We show that a green laser coupled to gold nanoparticles can ach...
Background and Objective: Laser photothermal therapy (PTT) is practiced at the moment using short la...
In this work, nanobiohybrids of plasmonic gold nanoparticles (AuNP, anti-angiogenic) and a peptide m...
The poor delivery of nanoparticles to target cancer cells hinders their success in the clinical sett...
national funds from FCT/MEC (UID/Multi/04378/2013) and co-financed by the ERDF under the PT2020 Part...
In this work, peptides designed to selectively interact with cellular receptors involved in the regu...
Careful design of nanoparticles plays a crucial role in their biomedical applications. It not only d...
Gold nanoparticles (AuNPs) have unique anti-angiogenic properties and have been applied in a variety...
We demonstrate the deliberate activation or inhibition of <i>in</i> <i>vitro</i> angiogenesis using ...
Objective: Today, nanotechnology is widely used in many fields because of its ability to alter the s...
Laser-induced techniques that employ the surface plasmon resonances of nanoparticles have recently b...
A new strategy to manipulate cell operations is demonstrated, based on membrane-receptor-specific in...
In this work, we aimed to develop a hybrid theranostic nano-formulation based on gold nanoparticles ...
FCT/MCTES - UID/Multi/04378/2019. FCT/MCTES - SFRH/BPD/124612/2016.Purpose: Progression of chronic m...
Angiogenesis is known as one of the hallmarks of cancer. Multiple lines evidence indicated that vasc...
Branched gold nanoparticles are potential photothermal therapy agents because of their large absorpt...
Background and Objective: Laser photothermal therapy (PTT) is practiced at the moment using short la...
In this work, nanobiohybrids of plasmonic gold nanoparticles (AuNP, anti-angiogenic) and a peptide m...
The poor delivery of nanoparticles to target cancer cells hinders their success in the clinical sett...
national funds from FCT/MEC (UID/Multi/04378/2013) and co-financed by the ERDF under the PT2020 Part...
In this work, peptides designed to selectively interact with cellular receptors involved in the regu...
Careful design of nanoparticles plays a crucial role in their biomedical applications. It not only d...
Gold nanoparticles (AuNPs) have unique anti-angiogenic properties and have been applied in a variety...
We demonstrate the deliberate activation or inhibition of <i>in</i> <i>vitro</i> angiogenesis using ...
Objective: Today, nanotechnology is widely used in many fields because of its ability to alter the s...
Laser-induced techniques that employ the surface plasmon resonances of nanoparticles have recently b...
A new strategy to manipulate cell operations is demonstrated, based on membrane-receptor-specific in...
In this work, we aimed to develop a hybrid theranostic nano-formulation based on gold nanoparticles ...
FCT/MCTES - UID/Multi/04378/2019. FCT/MCTES - SFRH/BPD/124612/2016.Purpose: Progression of chronic m...
Angiogenesis is known as one of the hallmarks of cancer. Multiple lines evidence indicated that vasc...
Branched gold nanoparticles are potential photothermal therapy agents because of their large absorpt...
Background and Objective: Laser photothermal therapy (PTT) is practiced at the moment using short la...
In this work, nanobiohybrids of plasmonic gold nanoparticles (AuNP, anti-angiogenic) and a peptide m...
The poor delivery of nanoparticles to target cancer cells hinders their success in the clinical sett...